A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Clinical trial NCT05490043 · TERMINATED

Trial details

NCT number: NCT05490043
Sponsor: Antengene (Hangzhou) Biologics Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Mature B-cell Non-Hodgkin Lymphoma

Start date: 2022-01-30
Primary completion: 2025-03-17
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.